文献速递主动脉疾病

重新定义腔内边界:医生改良腔内移植物在2区胸主动脉腔内修复中的系统综述

Redefining Endovascular Boundaries: A Systematic Review of Physician-Modified Endovascular Grafts in Zone 2 Thoracic Endovascular Aortic Repair.
PubMed 文献 · Ann Vasc Surg · 2025-08-13

该系统综述评估医生改良腔内移植物(PMEGs)在2区胸主动脉腔内修复(TEVAR)中的技术成功、临床结果和安全性。PMEGs是2区TEVAR可行有效的替代方案,尤其适用于紧急或解剖复杂的病例。

要点

  • PMEGs在2区TEVAR中技术成功率高,左锁骨下动脉通畅率超过94%。
  • 围手术期卒中风险2-6%,脊髓缺血风险≤2%,30天死亡率2.9-10%。
  • 中期随访显示装置稳定,无移位或断裂,再干预需求少。

核心结论

  • PMEGs是2区TEVAR可行且有效的替代方案,技术成功率高、并发症率低、中期耐久性良好。

主要发现

  • PMEGs技术成功率83.3%-100%,左锁骨下动脉通畅率超过94%。
  • 30天死亡率2.9-10%,主要发生在紧急病例。
  • 卒中发生率2-6%,脊髓缺血发生率≤2%。
  • Ia型和III型内漏不常见,多保守处理或腔内再干预。
  • 中期随访(12-49个月)显示装置稳定,无移植物移位或断裂,再干预需求少。

关键数值与推荐

  • 技术成功率83.3%-100%,左锁骨下动脉通畅率超过94%。
  • 30天死亡率2.9-10%,卒中发生率2-6%,脊髓缺血≤2%。
  • 中期随访12-49个月,无移植物移位或断裂报道。

临床怎么用

  • PMEGs可用于择期和紧急2区TEVAR,尤其适合解剖复杂或需保留左锁骨下动脉的病例。
  • 与杂交和开放手术相比,PMEGs在紧急或解剖复杂2区TEVAR中表现更有利。

局限性

  • 需要进一步长期研究来优化PMEGs在主动脉弓修复中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic endovascular aortic repair (TEVAR) offers a less invasive alternative to open surgery for aortic pathologies, but zone 2 repair remains complex due to the need for secure landing zones and preservation of the left subclavian artery (LSA). Physician-modified endovascular grafts (PMEGs) have emerged as flexible and rapid solution in both elective and emergency settings. This systematic review evaluates the technical success, clinical outcomes, and safety profile of PMEGs in zone 2 TEVAR. METHODS: A comprehensive review of the literature was conducted in scientific databases. Studies evaluating the use of PMEGs in zone 2 TEVAR were included. Quality assessment was performed using the Newcastle-Ottawa scale. RESULTS: Fourteen studies were included. PMEGs achieved high technical success rates ranging from 83.3% to 100%, with LSA patency rates exceeding 94% and low 30-day mortality (2.9-10%), primarily in emergency cases. Stroke occurred in 2-6% of patients, whereas spinal cord ischemia (SCI) was reported in ≤ 2% of cases. Type Ia and III endoleaks were uncommon, with most being managed conservatively or via endovascular reintervention. Mid-term follow-up (12-49 months) demonstrated excellent device stability, with no reports of graft migration or fracture and minimal need for reintervention. PMEGs performed favorably compared to hybrid and open approaches, particularly in urgent or anatomically complex zone 2 TEVAR. CONCLUSION: PMEGs are viable and effective alternatives for zone 2 TEVAR, offering high technical success, low complication rates, and promising mid-term durability. Further long-term studies are needed to optimize their role in aortic arch repair.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Putra RM, Putranto JNE, Budiarto RM, et al. Redefining Endovascular Boundaries: A Systematic Review of Physician-Modified Endovascular Grafts in Zone 2 Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2025. PMID: 40816492. doi:10.1016/j.avsg.2025.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。